These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1089 related articles for article (PubMed ID: 22104359)
1. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy. Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease. Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
4. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
5. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986 [TBL] [Abstract][Full Text] [Related]
6. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079 [TBL] [Abstract][Full Text] [Related]
7. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer. Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798 [TBL] [Abstract][Full Text] [Related]
8. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642 [TBL] [Abstract][Full Text] [Related]
9. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650 [TBL] [Abstract][Full Text] [Related]
10. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases]. Zhang GQ; Han F; Gao SL; A DL; Pang ZL Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944 [TBL] [Abstract][Full Text] [Related]
11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
12. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206 [TBL] [Abstract][Full Text] [Related]
13. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884 [TBL] [Abstract][Full Text] [Related]
15. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380 [TBL] [Abstract][Full Text] [Related]
16. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Gielda BT; Mehta P; Khan A; Marsh JC; Zusag TW; Warren WH; Fidler MJ; Abrams RA; Bonomi P; Liptay M; Faber LP Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):985-91. PubMed ID: 20932684 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470 [TBL] [Abstract][Full Text] [Related]
18. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394 [TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy. Massabeau C; Filleron T; Wakil G; Rouquette I; Bachaud JM; Leguellec S; Delisle MB; Toulas C; Mazieres J; Cohen-Jonathan Moyal E Clin Lung Cancer; 2012 Jan; 13(1):59-67. PubMed ID: 21856239 [TBL] [Abstract][Full Text] [Related]
20. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer]. Yu DP; Bai LQ; Xu SF; Han M; Wang ZT Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]